• Solutions
  • Clinical Need
  • Clinical Evidence
  • About Us
HemoCath — Heart Failure Management Platform
  • Solutions
  • Clinical Need
  • Clinical Evidence
  • About Us

Engineering better solutions for people with heart failure

HemoCath

HemoCath™ PA catheter
The HemoCath™ pulmonary artery catheter (4F) directly measures the two most important metrics (PAP,CVP) for heart failure management (HFM).

Substantially less invasive, more accurate
and easier-to-use than existing PA catheters. Temporarily inserted into a brachial vein on the arm and positioned into the pulmonary artery. 

Cloud-connected to the Luc™ HFM platform for remote HF/PAP monitoring

PA: pulmonary artery
PAP: pulmonary artery pressure
​CVP: central venous pressure

Picture
Picture
Luc™ AI-powered HFM platform
Remote HF/PAP monitoring and optimal AI-powered management of HF patients in hospitals/home  —  improving cardiac care  ​—  reducing HF hospitalizations  —  hospital cost savings.  ​
Picture
Picture
The HemoCath™ PA catheter and Luc™ HFM platform  are not currently approved for clinical use.​
© 2023 HemoCath Ltd. All rights reserved. HemoCath, Luc HFM and HemoCath logo are trademarks of HemoCath Ltd.​
  • Solutions
  • Clinical Need
  • Clinical Evidence
  • About Us